Ahora contratando: ¿Es usted un ingeniero de software de IA de primera línea motivado y motivado?

Horario de oficina: 08:00 a. m. a 6:00 p. m.

 

Llama en cualquier momento 24/7

(+1) 307-278-9811
 

Envíenos un correo electrónico para obtener ayuda

[email protected]
 

Dirección de la oficina

Italia, España, Estados Unidos

Detecting COPD with RE.DOCTOR Smartphone Tool

monitorización del sueño

COPD, the third leading cause of death globally, affects an estimated 12.5 million people in the US, leading to 150,000 deaths annually.

The disease is also one of the most expensive chronic conditions, generating healthcare costs of over $30 billion per year in the US. Much of that cost is driven by exacerbations, the sudden and life-threatening deterioration in lung function experienced by COPD patients.

Exacerbation of chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) lead to high health care costs owing to increased emergency room (ER) visits and hospitalizations.
Early interventions aim to improve the monitoring of symptoms to detect early deterioration and provide self-management strategies.
 
El RE.DOCTOR COPD SDK can be added to any smartphone app to assist in the diagnosis and treatment support of COPD patients. Learn more at https://re.doctor/en/
#COPD #copd #copdawareness
 
 

 

Relacionado Correo

RE.DOCTOR Vitals PPG device in monitoring blood glucose (BG) levels across a diverse pediatric population.

Pediatric Blood Glucose

23 Vistas
pediatric diabetes screening

Unlocking the Future

16 Vistas
biosensores

RE.DOCTOR Vital Signs

15 Vistas

Los comentarios están cerrados.

Comentarios recientes

    Entradas recientes